ÂÜÀòÂÒÂ×

Frederik Peissert is currently working as a Business Development Manager and Industrial Ph.D. student at Philochem AG, where Frederik is involved in isolating and characterizing novel fully human monoclonal antibodies against tumor-associated antigens. Frederik holds a Master of Science degree in Pharmaceutical Sciences from ETH Zurich and a Bachelor of Science degree in Molecular Medicine from the University of Tübingen.